JOANNE GALASSO: Open Payments
NPI 1932505211 · MARLTON, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$366 in 16 payments from 5 companies in 2025. Trend: 2023 $658 · 2024 $552 · 2025 $366
Food & beverage: $366
| Company | Payments | Amount |
|---|---|---|
| GlaxoSmithKline, LLC. | 8 | $172 |
| ABBVIE INC. | 3 | $81 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $50 |
| Kerecis Limited | 1 | $35 |
| Vanda Pharmaceuticals Inc. | 1 | $29 |
Products named: TRELEGY ELLIPTA, VRAYLAR, CAPLYTA, Kerecis SurgiClose, FANAPT, NUCALA.
Industry payments across NJ — which companies pay providers there.
